ArticleTrials2021

A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.

Benjamin Speich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.